
About Skanda Life Sciences
Skanda Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2012. Company offering drug discovery and preclinical development services. The company has 28 employees. Its Indian entity Skanda Lifesciences Private Limited reported revenue of βΉ4.02 Cr. Skanda Life Sciences offers products and services including Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery.
Company details
Skanda Life sciences is a provider of integrated and collaborative drug discovery and preclinical development services to the institutions, pharmaceutical, biotech, nutraceuticals, herbals and healthcare industries. Its services include custom synthesis, analytical service, impurities, building blocks, speciality chemicals, phyto (or) herbal reference standards, cell-based assays, bioassays and immunoassays, antimicrobial , anti fungal, anti viral, PT test, Ames test and pyrogenicity. It also provides preclinical services such as ADME studies, In-Vitro and In-Vivo DMPK services, Caco2 MDCK assays etc and analytical and bioanalytical services.
- Headquarters Bengaluru, India
- Employees 28
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website skandalifesciences.com
- Legal Name Skanda Lifesciences Private Limited
- Date of Incorporation 13 Nov, 2012
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹4.02 Cr
FY 2025 · +16% YoY
- Net Profit₹36.3 Lakh
FY 2025 · 9% margin
- EBITDA₹91.2 Lakh
FY 2025 · 23% margin
- Investors
- Employee Count28
Associated legal entities of Skanda Life Sciences
Skanda Life Sciences operates through Skanda Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Skanda Lifesciences Private Limited CIN U73100KA2012PTC066675 | Active | 13 Nov 2012 | Bangalore, Karnataka | ₹4.0 Cr | 28 | 2 | View details |
Products & Services of Skanda Life Sciences
Skanda Life Sciences offers a comprehensive portfolio of products and services, including Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development.
Provides drug discovery and development processes for clients
Focuses on developing medicinal compounds and molecules
Offers chemical analysis for pharmaceutical applications
Conducts in vivo and in vitro studies for drug testing
Funding Insights of Skanda Life Sciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Skanda Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Skanda Life Sciences
Skanda Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Startup Karnataka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India |
Investor details for Skanda Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Skanda Lifesciences Private Limited (Skanda Life Sciences)
Skanda Lifesciences Private Limited is the primary company behind Skanda Life Sciences. The board of Skanda Lifesciences Private Limited currently have 2 directors; the longest-serving is Swathi Shetty, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Swathi Shetty DIN 06388493 | Director | 13 Nov 2012 | 13 yrs 11 mo | Skanda Lifesciences Private Limited |
| Shivnna Yogisha DIN 06388499 | Director | 13 Nov 2012 | 13 yrs 11 mo | Skanda Lifesciences Private Limited |
Financials of Skanda Life Sciences
Figures of Skanda Lifesciences Private Limited, the primary company behind Skanda Life Sciences, for FY 2025. Revenue was ₹4.02 Cr (+16% year on year). Net profit was ₹36.3 Lakh (9% margin). EBITDA was ₹91.2 Lakh (23% margin). Revenue has grown at a compounded annual rate of +8% over three years and +19% over five years.
- ₹4.02 CrRevenue · FY 2025 · +16% YoY
- ₹36.3 LakhNet profit · 9% margin
- ₹91.2 LakhEBITDA · 23% margin
- ₹10 LakhPaid-up capital
- 28Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Skanda Lifesciences Private Limited are on its company page.
Detailed financial statements for Skanda Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Skanda Life Sciences
2 dated milestones of Skanda Life Sciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Skanda Life Sciences is founded.
- Funding First funding round.
Web traffic of Skanda Life Sciences
Websites that share an audience with Skanda Life Sciences (skandalifesciences.com).
Websites whose visitors overlap most with Skanda Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Skanda Life Sciences
Skanda Life Sciences was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Skanda Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Skanda Life Sciences has 28 employees.
The primary company behind Skanda Life Sciences, Skanda Lifesciences Private Limited, reported revenue of βΉ4.02 Cr for FY 2025, up 16% year on year.
Skanda Life sciences is a provider of integrated and collaborative drug discovery and preclinical development services to the institutions, pharmaceutical, biotech, nutraceuticals, herbals and healthcare industries. Its services include custom synthesis, analytical service, impurities, building blocks, speciality chemicals, phyto (or) herbal reference standards, cell-based assays, bioassays and immunoassays, antimicrobial , anti fungal, anti viral, PT test, Ames test and pyrogenicity. It also provides preclinical services such as ADME studies, In-Vitro and In-Vivo DMPK services, Caco2 MDCK assays etc and analytical and bioanalytical services.
Skanda Life Sciences offers Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development.
Skanda Life Sciences has 1 investor. Key investors include Startup Karnataka.
Skanda Life Sciences operates through Skanda Lifesciences Private Limited.
The legal entities of Skanda Life Sciences currently have 2 directors, including Swathi Shetty, Shivnna Yogisha.